Dornase Alfa and Cisplatin in Refractory Germ Cell Cancer.
Dornase Alfa and Cisplatin in Refractory Germ Cell Cancer.
Recruiting · NCT07121322 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dornase Alfa and Cisplatin in Refractory Germ Cell Cancer. | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, neoplasm | Recruiting | Phase 2 | 2026-09-25 | NCT07121322 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute, Slovakia | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Cancer Institute | Bratislava | Slovakia | 1 |